Trials / Unknown
UnknownNCT06119958
Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects
A Two-arm, Open-label, Single-sequence, Multiple Oral Dosings, Crossover Clinical Trial to Evaluate the Safety and the Pharmacokinetic Interaction of DWC202313 and DWC202314 in Healthy Adult Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is A two-arm, open-label, single-sequence, multiple oral dosings, crossover study to evaluate the safety and the pharmacokinetic interaction of DWC202313 and DWC202314 in healthy adult volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWC202313 | Experimental Drug 1 |
| DRUG | DWC202314 | Experimental Drug 2 |
Timeline
- Start date
- 2023-10-27
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2023-11-07
- Last updated
- 2023-11-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06119958. Inclusion in this directory is not an endorsement.